Organigram Global (OGI) Notes Payables (2021 - 2026)

Organigram Global (OGI) posted quarterly Notes Payables of $10.3 million for Q1 2026, down 13.93% quarter-over-quarter from $12.0 million in Q4 2025.

Organigram Global (OGI) Notes Payables (2021 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Notes Payables for 3 consecutive years, with $10.3 million the latest figure, recorded in Q1 2026.

In Q1 2026, Notes Payables changed N/A year-over-year to $10.3 million; the TTM figure through Mar 2026 stood at $10.3 million (changed N/A YoY), while the FY2025 annual figure was $12.0 million, changed N/A from the prior year.
Notes Payables declined to $10.3 million in Q1 2026 per OGI's latest filing, from $12.0 million in the prior quarter.
Across five years, Notes Payables topped out at $21.0 million in Q3 2025 and bottomed at $10.3 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-
2	Teva Pharmaceutical Industries	43.01 Bn	39.35 Bn	2.15 Bn
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.17 Bn	19.51 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-
10	Organigram Global	151.29 Mn	151.17 Mn	28.97 Mn

Download Data